Delay To Diagnosis In Digestive Cancerology By The General Practitioner Related To Covid-19 Pandemic Confinement

Study Overview

Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement

Objective: the pre-hospital management of cancers is little known in General Medicine. The first lockdown related to the COVID-19 pandemic led to the closure of health facilities. Investigators were interested in the diagnosis and care pathway of digestive cancers in post-confinement in General Medicine in Nouvelle-Aquitaine.

Method: patient records discussed in Digestive Oncology CPR of Bordeaux University Hospital for the first time from June 1 to August 31, 2020 and over the same period in 2019 were included. A questionnaire on the dates of the first symptoms, first consultation with the general practitioner, imaging examination and access to the specialist was sent to the general practitioner. The primary outcome was time from onset to date of first MDT.

Neoplasms, Colorectal
General Practitioner
Pandemic, COVID-19
Neoplasm, Liver
Neoplasms Pancreatic
Diagnosis
Advanced Cancer

2023-A02271-44

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates	Results Reporting Dates	Study Record Updates
First Submitted 2023-10-25	Results First Submitted N/A	Last Update Submitted that met QC Criteria 2023-11-01
First Submitted that Met QC Criteria 2023-11-01	Results First Submitted that Met QC Criteria N/A	Last Update Posted (ACTUAL) 2023-11-07
First Posted (ACTUAL) 2023-11-07	Results First Posted N/A	Last Verified 2023-11

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A

Allocation:
N/A

Interventional Model:
N/A

Masking:
N/A

Arms and Interventions

Participant Group/Arm	Intervention/Treatment
: 2019 patients diagnosed in 2019
: 2020 patients diagnosed in 2020

Primary Outcome Measures	Measure Description	Time Frame
time from date of first symptoms of cancer to the date of first MDT	time from date of first symptoms of cancer to the date of first MDT	DAYS

Secondary Outcome Measures	Measure Description	Time Frame
time from date of first symptoms to date of first consultation with a general practitioner,	time from date of first symptoms to date of first consultation with a general practitioner,	DAYS
time from date of first symptoms to first imaging or specific examination,	difficulties in referral to imaging,	DAYS
time from date of first symptoms to consultation with a specialist,	difficulties in referral to a specialist,	DAYS
stage of pathology by type of cancer,	stage of pathology by type of cancer according to TNM classification (tumor, node, metastatic status)	at inclusion
frequency of different types of cancer,	PERCENTAGE of each type of cancers in this study	at inclusion
overall survival.	overall survival.	MONTHS, time from from date of first symptoms to date of death

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

residing in New Aquitaine and
whose general practitioner practiced in New Aquitaine
malignant tumors of the esophagus, stomach, small intestine, colon, recto-sigmoid junction, rectum, anus and anal canal, liver and intrahepatic bile ducts, extrahepatic bile ducts, gallbladder and pancreas.
to have had at least one consultation or hospitalization in the digestive pole of the Bordeaux University Hospital within 6 months after the MDT.

Patients under 18 years of age,
who had already had a MDT for this cancer,
whose date of first MDT was outside the inclusion dates,
whose new cancer was a digestive metastasis of a primary of another location,
who did not have French health insurance

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available

Learn

Resources

PatientS

Caregivers

Clinical Trial Record